Leap Therapeutics, Inc. (LPTX) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -3.43M | -6.62M | -16.29M | -14.49M | -14.48M | -15.51M | -15.6M | -13.67M | -15.52M | -10.38M | -10.49M | -10.19M |
| Operating CF Margin % | - | - | -7795.22% | - | - | -6629.06% | - | - | - | -3080.12% | - | - |
| Operating CF Growth % | 76.31% | 57.33% | -4.44% | -5.96% | 6.68% | -49.44% | -48.74% | -34.23% | -22.17% | 20.24% | 14.4% | 16.92% |
| Net Income | -77.17M | -47.51M | -25.97M | -16.64M | -15.44M | -15.43M | -18.18M | -20.13M | -13.82M | -12.46M | -13.7M | -13.39M |
| Depreciation & Amortization | 0 | 0 | 775K | 0 | 0 | 0 | -202K | 0 | 5K | 4K | -199K | 106K |
| Stock-Based Compensation | 2.13M | 3.9M | 2.16M | 1.49M | 1.2M | 1.55M | 1.34M | 0 | 1.25M | 1.25M | 1.3M | 1.26M |
| Deferred Taxes | -5.12M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 501K | 0 |
| Other Non-Cash Items | 77.56M | 40.43M | 5M | 116K | 114K | 439K | 3.57M | 1.26M | 116K | -834K | 306K | 195K |
| Working Capital Changes | -832K | -3.44M | 1.75M | 552K | -363K | -2.07M | -2.13M | 5.19M | -3.06M | 1.66M | 1.3M | 1.64M |
| Change in Receivables | 0 | 0 | 46K | -4K | -55K | 0 | 498K | -251K | -247K | 23K | 1.85M | -297K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -1.57M | -4.75M | 0 | 969K | -373K | -1.67M | -114K | 5.07M | -2.39M | 0 | -624K | 1.81M |
| Cash from Investing | -9M | -97M | 13.99M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -348K |
| Capital Expenditures | -4M | -97M | -1.99M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | 953.11% | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 50.36M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 15.98M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -50.71M |
| Cash from Financing | 5.08M | 107.95M | 213K | -119K | -61K | 104K | -66K | 37.12M | 29K | 0 | -1K | 0 |
| Debt Issued (Net) | -182K | -123K | -13K | -119K | -77K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 5.11M | 108.07M | 0 | 0 | 16K | 104K | 39.93M | -2.88M | 29K | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | -234K | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 150K | 0 | 226K | 0 | 0 | 0 | -39.77M | 40M | 0 | 0 | -1K | 0 |
| Net Change in Cash | -7.35M | 4.35M | -2.09M | -14.58M | -14.54M | -15.57M | -15.66M | 23.56M | -15.72M | -10.1M | -10.67M | -10.62M |
| Free Cash Flow | -3.43M | -43.45M | -18.28M | -14.49M | -14.48M | -15.51M | -15.6M | -13.67M | -15.52M | -10.38M | -10.49M | -10.19M |
| FCF Margin % | - | - | -8748.33% | - | - | -6629.06% | - | - | - | -3080.12% | - | - |
| FCF Growth % | 76.31% | -180.08% | -17.21% | -5.96% | 6.68% | -49.44% | -48.74% | -34.23% | -22.17% | 20.24% | 14.4% | 16.92% |
| FCF per Share | -0.02 | -0.61 | -0.44 | -0.35 | -0.35 | -0.38 | -0.38 | -0.35 | -0.57 | -0.38 | -0.39 | -0.69 |
| FCF Conversion (FCF/Net Income) | 0.04x | -0.11x | 0.63x | 0.87x | 0.94x | 0.39x | 0.86x | 0.68x | 1.12x | 0.42x | 0.77x | 0.76x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |